VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 77 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,084,202 | +244.3% | 139,897 | +408.7% | 0.00% | – |
| Q2 2023 | $314,898 | -14.2% | 27,502 | -42.3% | 0.00% | – |
| Q1 2023 | $367,220 | +270.5% | 47,629 | +193.1% | 0.00% | – |
| Q4 2022 | $99,119 | +27.1% | 16,249 | +23.0% | 0.00% | – |
| Q3 2022 | $78,000 | -66.5% | 13,215 | -66.5% | 0.00% | – |
| Q2 2022 | $233,000 | -65.2% | 39,390 | -55.2% | 0.00% | – |
| Q1 2022 | $669,000 | +1927.3% | 87,867 | +620.2% | 0.00% | – |
| Q4 2021 | $33,000 | -64.9% | 12,201 | -66.0% | 0.00% | – |
| Q3 2021 | $94,000 | -24.2% | 35,910 | +20.1% | 0.00% | – |
| Q2 2021 | $124,000 | +19.2% | 29,896 | +34.3% | 0.00% | – |
| Q1 2021 | $104,000 | +8.3% | 22,256 | +66.5% | 0.00% | – |
| Q4 2020 | $96,000 | -78.1% | 13,366 | -67.5% | 0.00% | – |
| Q3 2020 | $438,000 | +54.2% | 41,149 | +82.9% | 0.00% | – |
| Q2 2020 | $284,000 | -16.0% | 22,501 | -39.2% | 0.00% | – |
| Q1 2020 | $338,000 | +103.6% | 36,991 | +211.0% | 0.00% | – |
| Q4 2019 | $166,000 | -89.3% | 11,895 | -86.7% | 0.00% | – |
| Q3 2019 | $1,545,000 | -12.3% | 89,723 | +38.7% | 0.00% | – |
| Q2 2019 | $1,761,000 | +159.0% | 64,674 | +81.9% | 0.00% | – |
| Q1 2019 | $680,000 | +580.0% | 35,553 | +234.2% | 0.00% | – |
| Q4 2018 | $100,000 | +53.8% | 10,637 | +211.0% | 0.00% | – |
| Q3 2018 | $65,000 | -87.2% | 3,420 | -86.9% | 0.00% | – |
| Q2 2018 | $509,000 | +220.1% | 26,046 | +207.7% | 0.00% | – |
| Q1 2018 | $159,000 | +16.9% | 8,466 | +3.1% | 0.00% | – |
| Q4 2017 | $136,000 | +491.3% | 8,211 | +649.9% | 0.00% | – |
| Q3 2017 | $23,000 | +283.3% | 1,095 | +51.2% | 0.00% | – |
| Q2 2017 | $6,000 | -92.6% | 724 | -88.1% | 0.00% | – |
| Q1 2017 | $81,000 | +6.6% | 6,109 | +2.0% | 0.00% | – |
| Q4 2016 | $76,000 | +38.2% | 5,992 | +31.5% | 0.00% | – |
| Q3 2016 | $55,000 | +10.0% | 4,555 | +0.3% | 0.00% | – |
| Q2 2016 | $50,000 | +1150.0% | 4,543 | +887.6% | 0.00% | – |
| Q1 2016 | $4,000 | +33.3% | 460 | +230.9% | 0.00% | – |
| Q4 2015 | $3,000 | – | 139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |